Biolidics Limited provided earnings guidance for the year ended December 31, 2022. The group is expected to report a higher net loss after tax for fiscal year 2022, as compared to the net loss after tax of approximately SGD 5.98 million for the previous financial year ended 31 December 2021. Based on the information currently available to the Company, the expected increase in net loss after tax for FY2022 as compared to FY2021 was mainly attributable to increases in (i) impairment losses on intangible assets, goodwill, and plant & equipment; (ii) allowance for inventories obsolescence; and (iii) employee benefits expenses.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.013 SGD | +30.00% | +18.18% | -7.14% |
06-17 | Biolidics’ CEO Steps Down; Shares Surge 10% | MT |
06-10 | Biolidics Places Subsidiary Under Voluntary Liquidation | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.14% | 7.14M | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B | |
+19.65% | 30.23B |
- Stock Market
- Equities
- 8YY Stock
- News Biolidics Limited
- Biolidics Limited Provides Group Earnings Guidance for the Financial Year Ended 31 December 2022